GLYCERIN

GLYCERIN was reported 13939 times

GLYCERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 155 0.5116
1 FIBULA AGENESIS 4 0.1600
2 EYE OPERATION COMPLICATION 19 0.1159
3 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 9 0.1125
4 HAEMOPHILUS SEPSIS 6 0.1053
5 FEMALE GENITAL TRACT FISTULA 158 0.0925
6 DEAFNESS PERMANENT 16 0.0816
7 MULTIPLE DRUG THERAPY 54 0.0716
8 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
9 AUTOIMMUNE ENTEROPATHY 6 0.0682
10 CHRONIC SINUSITIS 228 0.0607
11 SEDATION COMPLICATION 154 0.0603
12 RADICULOPATHY 159 0.0603
13 ENDOCRINE OPHTHALMOPATHY 49 0.0565
14 BURKHOLDERIA TEST POSITIVE 7 0.0565
15 PROCTITIS 158 0.0563
16 AUTOPHONY 4 0.0533
17 ACUTE PHOSPHATE NEPHROPATHY 8 0.0513
18 MACULAR DEGENERATION 603 0.0504
19 CREATININE RENAL CLEARANCE DECREASED 166 0.0414
20 ANTI-THYROID ANTIBODY INCREASED 5 0.0397
21 PERIORBITAL PAIN 27 0.0319
22 EYELID PAIN 45 0.0221
23 POSITIVE AIRWAY PRESSURE THERAPY 6 0.0205
24 CORNEAL INFILTRATES 6 0.0191
25 FALSE POSITIVE INVESTIGATION RESULT 19 0.0188
26 CORNEAL EPITHELIUM DEFECT 10 0.0172
27 CORNEAL THINNING 4 0.0156
28 OESOPHAGEAL INJURY 6 0.0155
29 VAGINAL DISCHARGE 155 0.0153
30 PARAESTHESIA ORAL 218 0.0151
31 BLOOD CALCIUM DECREASED 168 0.0149
32 RENAL FUNCTION TEST ABNORMAL 69 0.0148
33 TYPE V HYPERLIPIDAEMIA 7 0.0144
34 KERATOCONJUNCTIVITIS SICCA 5 0.0136
35 BACTERIAL TRANSLOCATION 4 0.0126
36 DEAFNESS NEUROSENSORY 40 0.0122
37 ORAL CANDIDIASIS 159 0.0121
38 CERUMEN IMPACTION 11 0.0120
39 CORNEAL PERFORATION 7 0.0111
40 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
41 FOREIGN BODY SENSATION IN EYES 70 0.0110
42 EYE INFECTION BACTERIAL 6 0.0108
43 CATARACT NUCLEAR 7 0.0105
44 FAT TISSUE DECREASED 4 0.0103
45 ORTHOSTATIC HYPOTENSION 171 0.0098
46 RENAL ABSCESS 8 0.0098
47 CORNEAL OPACITY 12 0.0088
48 KERATITIS 26 0.0085
49 HYPOAESTHESIA EYE 5 0.0085
50 CORNEAL DEPOSITS 6 0.0081
51 CORNEAL SCAR 4 0.0080
52 BRAIN NEOPLASM BENIGN 4 0.0078
53 ALLERGIC COUGH 6 0.0078
54 EYE PAIN 427 0.0076
55 CORNEAL EROSION 4 0.0074
56 CORNEAL ABRASION 10 0.0073
57 INJECTION RELATED REACTION 12 0.0073
58 ASTIGMATISM 11 0.0073
59 PROCEDURAL PAIN 200 0.0072
60 EUSTACHIAN TUBE DYSFUNCTION 4 0.0069
61 EYE ULCER 4 0.0069
62 PRODUCT CONTAMINATION MICROBIAL 8 0.0067
63 OCULAR DISCOMFORT 74 0.0066
64 CORNEAL TRANSPLANT 5 0.0064
65 BLOOD ALKALINE PHOSPHATASE DECREASED 6 0.0063
66 GROWTH OF EYELASHES 5 0.0063
67 CORNEAL OEDEMA 14 0.0062
68 SEDATION 160 0.0061
69 CARBON DIOXIDE DECREASED 7 0.0061
70 INSTILLATION SITE PAIN 15 0.0060
71 FREQUENT BOWEL MOVEMENTS 163 0.0060
72 SUPERINFECTION 9 0.0060
73 CORNEAL DISORDER 13 0.0059
74 ABNORMAL SENSATION IN EYE 25 0.0058
75 SOFT TISSUE DISORDER 6 0.0054
76 DRY AGE-RELATED MACULAR DEGENERATION 6 0.0054
77 EYE IRRITATION 301 0.0052
78 RED BLOOD CELLS URINE POSITIVE 5 0.0052
79 EYE ALLERGY 8 0.0052
80 ULCERATIVE KERATITIS 14 0.0051
81 VITREOUS DETACHMENT 11 0.0051
82 VOLVULUS 12 0.0051
83 NEPHROCALCINOSIS 6 0.0051
84 PHOTOPHOBIA 92 0.0049
85 COLITIS 182 0.0048
86 ASTHENOPIA 26 0.0047
87 CONJUNCTIVITIS ALLERGIC 7 0.0047
88 CHOROIDAL NEOVASCULARISATION 4 0.0047
89 DEPRESSED LEVEL OF CONSCIOUSNESS 184 0.0046
90 BLOOD CHLORIDE INCREASED 8 0.0046
91 EYELID MARGIN CRUSTING 13 0.0045
92 BLOOD ALBUMIN INCREASED 4 0.0045
93 KERATOPATHY 7 0.0044
94 EYELID IRRITATION 11 0.0044
95 PUSTULE 10 0.0042
96 PRODUCT USE COMPLAINT 65 0.0041
97 MONOCYTE COUNT DECREASED 5 0.0041
98 ERYTHEMA OF EYELID 22 0.0041
99 BLEPHARITIS 16 0.0040
100 RECTAL HAEMORRHAGE 171 0.0040
101 DACRYOSTENOSIS ACQUIRED 5 0.0039
102 COGNITIVE DISORDER 180 0.0039
103 NASAL ULCER 6 0.0038
104 EYE DISCHARGE 39 0.0037
105 BLOOD SODIUM INCREASED 10 0.0037
106 CONJUNCTIVAL HYPERAEMIA 13 0.0036
107 CLOSTRIDIUM TEST POSITIVE 8 0.0036
108 RHINOVIRUS INFECTION 14 0.0036
109 COLITIS ULCERATIVE 160 0.0036
110 RENAL FAILURE CHRONIC 27 0.0035
111 AORTIC ARTERIOSCLEROSIS 9 0.0035
112 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
113 BRONCHIOLITIS 12 0.0034
114 LACRIMATION INCREASED 102 0.0034
115 INFUSION RELATED REACTION 222 0.0033
116 SWELLING OF EYELID 21 0.0033
117 MONOCYTE COUNT INCREASED 12 0.0033
118 ESSENTIAL HYPERTENSION 6 0.0033
119 HYPERPHOSPHATAEMIA 7 0.0033
120 EXOPHTHALMOS 7 0.0033
121 EYE INFLAMMATION 31 0.0032
122 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 231 0.0032
123 HAEMATOCHEZIA 177 0.0032
124 OSTEOSCLEROSIS 5 0.0032
125 RHINITIS ALLERGIC 14 0.0031
126 NEUTROPHIL COUNT INCREASED 32 0.0031
127 PYELONEPHRITIS ACUTE 6 0.0031
128 EYELID DISORDER 7 0.0030
129 BILIRUBIN CONJUGATED INCREASED 7 0.0030
130 OCULAR HYPERAEMIA 142 0.0030
131 PHYSICAL DISABILITY 13 0.0029
132 CARBON DIOXIDE INCREASED 4 0.0029
133 PARANASAL SINUS DISCOMFORT 11 0.0029
134 SUBILEUS 6 0.0029
135 DRY EYE 142 0.0028
136 NEPHROGENIC ANAEMIA 13 0.0028
137 PRODUCT DELIVERY MECHANISM ISSUE 15 0.0028
138 LYMPHOCYTE COUNT INCREASED 9 0.0028
139 ENDOMETRIAL CANCER 6 0.0027
140 BLOOD CHLORIDE DECREASED 7 0.0027
141 HYPOPROTEINAEMIA 5 0.0026
142 GINGIVAL RECESSION 5 0.0026
143 INFUSION SITE INFECTION 6 0.0026
144 ABDOMINAL RIGIDITY 7 0.0026
145 MOBILITY DECREASED 183 0.0025
146 VITREOUS FLOATERS 25 0.0025
147 TUMOUR HAEMORRHAGE 7 0.0025
148 HYPERURICAEMIA 10 0.0024
149 ARTERIOSCLEROSIS CORONARY ARTERY 16 0.0024
150 KLEBSIELLA INFECTION 12 0.0024
151 FAECALOMA 13 0.0024
152 NEUROGENIC BLADDER 5 0.0024
153 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
154 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
155 ENTERITIS INFECTIOUS 4 0.0023
156 CONSTIPATION 512 0.0023
157 BLADDER DISORDER 23 0.0023
158 BALANCE DISORDER 198 0.0023
159 RESPIRATORY ACIDOSIS 9 0.0023
160 DYSPEPSIA 221 0.0022
161 TONGUE BLISTERING 5 0.0022
162 PSEUDOMEMBRANOUS COLITIS 5 0.0022
163 GASTROINTESTINAL INJURY 6 0.0022
164 EAR CONGESTION 6 0.0022
165 HYPERNATRAEMIA 11 0.0022
166 DEVICE ALARM ISSUE 4 0.0022
167 HAEMATOCRIT INCREASED 5 0.0022
168 BLOOD PHOSPHORUS DECREASED 8 0.0022
169 EYE SWELLING 81 0.0022
170 URINE OUTPUT DECREASED 19 0.0022
171 ADENOCARCINOMA OF COLON 4 0.0021
172 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
173 PERIORBITAL SWELLING 12 0.0021
174 GINGIVAL SWELLING 9 0.0020
175 HYPERPARATHYROIDISM SECONDARY 5 0.0020
176 LUNG ADENOCARCINOMA 6 0.0020
177 BLOOD THYROID STIMULATING HORMONE DECREASED 9 0.0020
178 FACIAL PARESIS 7 0.0020
179 DECUBITUS ULCER 16 0.0020
180 MEAN CELL VOLUME INCREASED 5 0.0019
181 EYELIDS PRURITUS 6 0.0019
182 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
183 LYMPHOCYTE COUNT DECREASED 34 0.0019
184 MOUTH SWELLING 11 0.0019
185 BUNDLE BRANCH BLOCK LEFT 8 0.0019
186 PNEUMONIA ASPIRATION 47 0.0019
187 PROTEIN TOTAL INCREASED 5 0.0019
188 INTRAOCULAR PRESSURE INCREASED 24 0.0019
189 PRODUCT CONTAINER ISSUE 16 0.0019
190 EYE INFECTION 21 0.0019
191 PROTEIN TOTAL DECREASED 7 0.0019
192 BLOOD UREA INCREASED 31 0.0018
193 SUBDURAL HAEMORRHAGE 5 0.0018
194 INFLAMMATORY MARKER INCREASED 9 0.0018
195 RASH MORBILLIFORM 5 0.0018
196 HIGH DENSITY LIPOPROTEIN DECREASED 6 0.0018
197 BACTERIAL TEST POSITIVE 4 0.0018
198 BLOOD ALBUMIN DECREASED 14 0.0018
199 CEREBRAL ATROPHY 7 0.0018
200 EYE PRURITUS 59 0.0018
201 IMPAIRED QUALITY OF LIFE 25 0.0017
202 EOSINOPHIL COUNT DECREASED 4 0.0017
203 ABSCESS LIMB 7 0.0016
204 EYELID OEDEMA 19 0.0016
205 PSEUDOMONAS INFECTION 14 0.0016
206 HORDEOLUM 7 0.0016
207 ILEUS 20 0.0016
208 BLOOD CREATININE DECREASED 5 0.0016
209 PHOTOPSIA 10 0.0016
210 PNEUMONIA VIRAL 5 0.0016
211 ILEUS PARALYTIC 7 0.0016
212 ANGLE CLOSURE GLAUCOMA 4 0.0016
213 PROCTALGIA 10 0.0016
214 SKIN EROSION 5 0.0016
215 LOW DENSITY LIPOPROTEIN INCREASED 12 0.0015
216 HIATUS HERNIA 20 0.0015
217 UROSEPSIS 14 0.0015
218 OTITIS MEDIA 5 0.0015
219 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
220 ENDOPHTHALMITIS 9 0.0015
221 PYELONEPHRITIS 13 0.0015
222 HYDRONEPHROSIS 11 0.0015
223 BLOOD PHOSPHORUS INCREASED 4 0.0015
224 ANAEMIA 278 0.0015
225 ENTEROCOCCAL INFECTION 7 0.0014
226 GASTRIC ULCER HAEMORRHAGE 8 0.0014
227 PRE-EXISTING CONDITION IMPROVED 9 0.0014
228 PRODUCT ADMINISTRATION ERROR 29 0.0014
229 INFUSION SITE SWELLING 9 0.0014
230 VISION BLURRED 196 0.0014
231 MACULAR OEDEMA 8 0.0014
232 SKIN INFECTION 16 0.0014
233 INFUSION SITE ERYTHEMA 12 0.0014
234 SKIN REACTION 20 0.0014
235 BREATH SOUNDS ABNORMAL 7 0.0014
236 FIBRIN D DIMER INCREASED 5 0.0014
237 PROTEIN URINE PRESENT 7 0.0014
238 VITAMIN D DECREASED 12 0.0014
239 NEUROLOGICAL SYMPTOM 8 0.0014
240 FLUID INTAKE REDUCED 7 0.0014
241 RENAL CYST 11 0.0014
242 BLOOD PARATHYROID HORMONE INCREASED 4 0.0014
243 BLOOD CALCIUM INCREASED 12 0.0014
244 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
245 SPINAL OSTEOARTHRITIS 12 0.0014
246 EAR DISCOMFORT 14 0.0014
247 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
248 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
249 FAILURE TO THRIVE 7 0.0013
250 ATELECTASIS 13 0.0013
251 MALNUTRITION 15 0.0013
252 BLOOD CULTURE POSITIVE 4 0.0013
253 COLITIS ISCHAEMIC 9 0.0013
254 VISUAL ACUITY REDUCED 44 0.0013
255 ANAL ABSCESS 7 0.0013
256 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
257 HYPOMAGNESAEMIA 18 0.0013
258 HAEMORRHOIDS 25 0.0013
259 ABDOMINAL PAIN 298 0.0013
260 LEUKOCYTOSIS 23 0.0013
261 PNEUMONIA FUNGAL 5 0.0013
262 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
263 SPUTUM DISCOLOURED 12 0.0013
264 DEMENTIA 35 0.0013
265 ACUTE RESPIRATORY FAILURE 24 0.0012
266 CANDIDIASIS 5 0.0012
267 WEIGHT DECREASED 347 0.0012
268 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
269 ENURESIS 5 0.0012
270 VITAMIN B12 DEFICIENCY 5 0.0012
271 FACIAL PAIN 11 0.0012
272 HYPOTENSION 247 0.0012
273 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
274 HYPOXIA 43 0.0012
275 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
276 ERYTHEMA 246 0.0012
277 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
278 EAR PAIN 23 0.0012
279 GASTROINTESTINAL PAIN 13 0.0012
280 EYELID PTOSIS 12 0.0012
281 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
282 PURULENT DISCHARGE 5 0.0012
283 ECCHYMOSIS 8 0.0012
284 PERIPHERAL VASCULAR DISORDER 6 0.0012
285 HYPOCALCAEMIA 22 0.0012
286 FEBRILE NEUTROPENIA 77 0.0012
287 BLOOD MAGNESIUM DECREASED 10 0.0012
288 CAROTID ARTERY STENOSIS 4 0.0011
289 VULVOVAGINAL DISCOMFORT 5 0.0011
290 DIVERTICULUM 8 0.0011
291 HOSPICE CARE 11 0.0011
292 CELLULITIS 56 0.0011
293 BONE LESION 4 0.0011
294 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
295 BACTERAEMIA 13 0.0011
296 MAJOR DEPRESSION 8 0.0011
297 EYE OPERATION 5 0.0011
298 PYREXIA 375 0.0011
299 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
300 MULTIPLE USE OF SINGLE-USE PRODUCT 6 0.0011
301 TINNITUS 49 0.0011
302 TOXICITY TO VARIOUS AGENTS 179 0.0011
303 SEASONAL ALLERGY 15 0.0011
304 CARDIAC FAILURE ACUTE 7 0.0010
305 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
306 COMMUNICATION DISORDER 4 0.0010
307 LIPASE INCREASED 8 0.0010
308 BLOOD URIC ACID INCREASED 6 0.0010
309 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
310 APHTHOUS ULCER 8 0.0010
311 NAIL DISORDER 9 0.0010
312 FAECES HARD 4 0.0010
313 HYPOVOLAEMIA 6 0.0010
314 EYE MOVEMENT DISORDER 7 0.0010
315 RESPIRATORY RATE INCREASED 9 0.0010
316 STAPHYLOCOCCAL SEPSIS 5 0.0010
317 CATARACT 60 0.0010
318 OESOPHAGITIS 11 0.0010
319 HYPERLIPIDAEMIA 12 0.0010
320 APHONIA 14 0.0010
321 ASPARTATE AMINOTRANSFERASE INCREASED 53 0.0010
322 FUNGAL SKIN INFECTION 4 0.0010
323 DYSLIPIDAEMIA 5 0.0010
324 PNEUMONIA BACTERIAL 9 0.0010
325 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
326 HYPOPHAGIA 25 0.0010
327 SMALL INTESTINAL OBSTRUCTION 12 0.0010
328 PERIORBITAL OEDEMA 5 0.0010
329 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
330 GASTROINTESTINAL PERFORATION 4 0.0010
331 EOSINOPHIL COUNT INCREASED 8 0.0010
332 HAEMATOCRIT DECREASED 19 0.0010
333 TACHYPNOEA 13 0.0010
334 BLEPHAROSPASM 6 0.0010
335 BRAIN OEDEMA 12 0.0009
336 HYPOPHOSPHATAEMIA 7 0.0009
337 RESPIRATORY TRACT CONGESTION 15 0.0009
338 EYE DISORDER 31 0.0009
339 HYPONATRAEMIA 53 0.0009
340 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
341 FALL 310 0.0009
342 OVERWEIGHT 5 0.0009
343 RENAL TUBULAR NECROSIS 9 0.0009
344 CONJUNCTIVITIS 17 0.0009
345 DIVERTICULUM INTESTINAL 4 0.0009
346 HYPOTHYROIDISM 29 0.0009
347 EJECTION FRACTION DECREASED 14 0.0009
348 HYPOALBUMINAEMIA 7 0.0009
349 ALANINE AMINOTRANSFERASE INCREASED 55 0.0009
350 PROTEINURIA 17 0.0009
351 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
352 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
353 HYPERCALCAEMIA 11 0.0009
354 PHARYNGITIS 11 0.0009
355 PAIN 544 0.0009
356 GLAUCOMA 17 0.0009
357 TRICUSPID VALVE INCOMPETENCE 7 0.0009
358 RESPIRATORY FAILURE 64 0.0009
359 RETINAL DETACHMENT 8 0.0009
360 HYPOKALAEMIA 40 0.0009
361 LARGE INTESTINE POLYP 6 0.0009
362 RALES 5 0.0009
363 ELECTROLYTE IMBALANCE 10 0.0009
364 SHOCK HAEMORRHAGIC 7 0.0009
365 DEVICE USE ISSUE 15 0.0009
366 HYPERTRIGLYCERIDAEMIA 5 0.0009
367 DISCOMFORT 52 0.0009
368 RENAL FAILURE ACUTE 36 0.0008
369 EMBOLISM 7 0.0008
370 CATARACT OPERATION 5 0.0008
371 SLEEP APNOEA SYNDROME 16 0.0008
372 VISUAL FIELD DEFECT 6 0.0008
373 HAEMOPTYSIS 23 0.0008
374 VITAMIN D DEFICIENCY 8 0.0008
375 DYSURIA 30 0.0008
376 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
377 PSYCHIATRIC SYMPTOM 6 0.0008
378 BODY TEMPERATURE DECREASED 8 0.0008
379 UVEITIS 11 0.0008
380 NEUTROPHIL COUNT DECREASED 33 0.0008
381 RASH MACULO-PAPULAR 18 0.0008
382 HEPATIC STEATOSIS 15 0.0008
383 INTESTINAL PERFORATION 9 0.0008
384 NASAL DRYNESS 5 0.0008
385 RESPIRATORY DISTRESS 22 0.0008
386 MITRAL VALVE INCOMPETENCE 9 0.0008
387 DERMATITIS CONTACT 9 0.0008
388 RHINORRHOEA 51 0.0008
389 TROPONIN INCREASED 6 0.0008
390 FAECES DISCOLOURED 17 0.0008
391 BLOOD CREATININE INCREASED 51 0.0008
392 FEMORAL NECK FRACTURE 4 0.0008
393 MALAISE 342 0.0008
394 BLOOD BILIRUBIN INCREASED 21 0.0008
395 DIPLOPIA 20 0.0008
396 PULMONARY HAEMORRHAGE 6 0.0008
397 MULTIPLE ALLERGIES 6 0.0008
398 COVID-19 PNEUMONIA 9 0.0008
399 IRON DEFICIENCY ANAEMIA 7 0.0008
400 NASAL DISCOMFORT 6 0.0008
401 DRUG ABUSE 63 0.0008
402 PNEUMOTHORAX 12 0.0008
403 HEPATIC FUNCTION ABNORMAL 28 0.0007
404 MENINGITIS 5 0.0007
405 FLANK PAIN 7 0.0007
406 RHINITIS 6 0.0007
407 RED BLOOD CELL COUNT DECREASED 21 0.0007
408 PANCYTOPENIA 41 0.0007
409 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
410 HICCUPS 6 0.0007
411 NEPHROTIC SYNDROME 5 0.0007
412 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
413 ONYCHOCLASIS 5 0.0007
414 ECONOMIC PROBLEM 11 0.0007
415 SPINAL COMPRESSION FRACTURE 6 0.0007
416 RESPIRATION ABNORMAL 5 0.0007
417 DROOLING 5 0.0007
418 DENTAL CARIES 8 0.0007
419 HAEMOGLOBIN DECREASED 74 0.0007
420 MENTAL STATUS CHANGES 20 0.0007
421 LARGE INTESTINE PERFORATION 5 0.0007
422 VISUAL IMPAIRMENT 89 0.0007
423 URINARY TRACT INFECTION 122 0.0007
424 HYPERKALAEMIA 25 0.0007
425 SEPTIC SHOCK 31 0.0007
426 SENSATION OF FOREIGN BODY 6 0.0007
427 CHOLECYSTITIS ACUTE 4 0.0007
428 ACUTE MYELOID LEUKAEMIA 11 0.0007
429 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
430 LOCALISED INFECTION 17 0.0007
431 NEUTROPENIC SEPSIS 5 0.0007
432 AGRANULOCYTOSIS 13 0.0007
433 ACUTE KIDNEY INJURY 107 0.0007
434 NEURALGIA 17 0.0007
435 CEREBRAL HAEMORRHAGE 25 0.0007
436 NECK PAIN 39 0.0007
437 CEREBRAL INFARCTION 17 0.0007
438 LETHARGY 40 0.0007
439 HEAD INJURY 22 0.0007
440 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
441 ENTEROCOLITIS 4 0.0007
442 MADAROSIS 8 0.0007
443 FAECES SOFT 5 0.0007
444 HYPERGLYCAEMIA 25 0.0007
445 THERAPY INTERRUPTED 49 0.0007
446 INCORRECT PRODUCT STORAGE 9 0.0007
447 GASTRIC ULCER 13 0.0007
448 TOOTH INFECTION 9 0.0007
449 ASCITES 20 0.0007
450 IMMUNOSUPPRESSION 6 0.0007
451 LUNG INFILTRATION 6 0.0007
452 DECREASED INTEREST 4 0.0007
453 BRADYKINESIA 4 0.0007
454 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
455 HYPERBILIRUBINAEMIA 7 0.0007
456 PLATELET COUNT DECREASED 72 0.0007
457 VENTRICULAR EXTRASYSTOLES 7 0.0007
458 TENDERNESS 7 0.0007
459 HAEMATURIA 23 0.0007
460 THIRST 12 0.0007
461 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
462 INTESTINAL OBSTRUCTION 25 0.0007
463 RENAL PAIN 7 0.0007
464 COAGULOPATHY 11 0.0007
465 STOMATITIS 40 0.0007
466 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
467 PLEURAL EFFUSION 40 0.0007
468 AORTIC ANEURYSM 5 0.0007
469 ACIDOSIS 5 0.0007
470 NEPHROLITHIASIS 30 0.0007
471 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
472 PRESCRIBED UNDERDOSE 13 0.0007
473 CANDIDA INFECTION 11 0.0007
474 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
475 SKIN LACERATION 7 0.0006
476 CARPAL TUNNEL SYNDROME 9 0.0006
477 PELVIC FRACTURE 5 0.0006
478 DEFORMITY 6 0.0006
479 DIARRHOEA HAEMORRHAGIC 6 0.0006
480 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
481 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
482 HEADACHE 400 0.0006
483 DEHYDRATION 85 0.0006
484 SEPSIS 71 0.0006
485 DELIRIUM 22 0.0006
486 BLOOD URINE PRESENT 12 0.0006
487 BLOOD POTASSIUM DECREASED 19 0.0006
488 DRUG INTERACTION 100 0.0006
489 URINARY RETENTION 21 0.0006
490 DRUG INEFFECTIVE 828 0.0006
491 CYSTITIS 20 0.0006
492 ENTERITIS 4 0.0006
493 DYSPHAGIA 59 0.0006
494 DERMATITIS 13 0.0006
495 SKIN ULCER 16 0.0006
496 MENTAL IMPAIRMENT 15 0.0006
497 DIZZINESS POSTURAL 6 0.0006
498 LACTIC ACIDOSIS 20 0.0006
499 THROMBOCYTOPENIA 69 0.0006
500 PLATELET COUNT INCREASED 8 0.0006
501 HEPATOMEGALY 6 0.0006
502 ABNORMAL FAECES 5 0.0006
503 ASPERGILLUS INFECTION 4 0.0006
504 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
505 GASTRIC HAEMORRHAGE 7 0.0006
506 GASTRITIS 16 0.0006
507 BRONCHITIS 45 0.0006
508 DISABILITY 12 0.0006
509 SINUS DISORDER 12 0.0006
510 PULMONARY MASS 9 0.0006
511 SECOND PRIMARY MALIGNANCY 5 0.0006
512 NAUSEA 473 0.0006
513 HYPOAESTHESIA ORAL 9 0.0006
514 NASAL CONGESTION 35 0.0006
515 EMPHYSEMA 6 0.0006
516 JAUNDICE 16 0.0006
517 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
518 BRONCHIECTASIS 4 0.0006
519 PNEUMONIA 192 0.0006
520 TASTE DISORDER 12 0.0006
521 HIP FRACTURE 19 0.0006
522 CHOLECYSTITIS 7 0.0006
523 OXYGEN SATURATION DECREASED 33 0.0006
524 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
525 TACHYCARDIA 52 0.0006
526 DEVICE RELATED INFECTION 9 0.0006
527 SKIN LESION 16 0.0006
528 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
529 MULTI-ORGAN FAILURE 10 0.0006
530 C-REACTIVE PROTEIN INCREASED 21 0.0006
531 PULMONARY HYPERTENSION 12 0.0006
532 ORAL DISCOMFORT 8 0.0006
533 EXTRASYSTOLES 4 0.0006
534 LOWER RESPIRATORY TRACT INFECTION 26 0.0006
535 EMOTIONAL DISTRESS 69 0.0006
536 HALLUCINATION, VISUAL 12 0.0006
537 TUMOUR LYSIS SYNDROME 5 0.0006
538 DUODENAL ULCER 4 0.0006
539 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
540 SHOCK 13 0.0006
541 OBESITY 9 0.0006
542 OFF LABEL USE 492 0.0006
543 BODY HEIGHT DECREASED 6 0.0006
544 SECRETION DISCHARGE 7 0.0006
545 ANAL INCONTINENCE 5 0.0006
546 DRY MOUTH 45 0.0006
547 ABDOMINAL PAIN LOWER 14 0.0006
548 HYPERTHYROIDISM 8 0.0006
549 OSTEOMYELITIS 10 0.0006
550 ASPIRATION 6 0.0005
551 BLOOD GLUCOSE FLUCTUATION 6 0.0005
552 BRADYCARDIA 29 0.0005
553 INCREASED TENDENCY TO BRUISE 5 0.0005
554 INFUSION SITE PAIN 7 0.0005
555 OSTEOARTHRITIS 23 0.0005
556 DRUG-INDUCED LIVER INJURY 17 0.0005
557 CYTOMEGALOVIRUS INFECTION 9 0.0005
558 DIVERTICULITIS 15 0.0005
559 DIABETIC KETOACIDOSIS 13 0.0005
560 PRODUCT DISTRIBUTION ISSUE 5 0.0005
561 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
562 IMMUNODEFICIENCY 8 0.0005
563 ERYTHEMA MULTIFORME 5 0.0005
564 HEPATIC ENCEPHALOPATHY 5 0.0005
565 MUCOSAL INFLAMMATION 14 0.0005
566 TYPE 2 DIABETES MELLITUS 18 0.0005
567 ARTERIOSCLEROSIS 5 0.0005
568 PERITONITIS 11 0.0005
569 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
570 CHEST PAIN 98 0.0005
571 SCAB 6 0.0005
572 NEUROPATHY PERIPHERAL 50 0.0005
573 EYE HAEMORRHAGE 7 0.0005
574 PRODUCTIVE COUGH 25 0.0005
575 BOWEL MOVEMENT IRREGULARITY 4 0.0005
576 SWELLING FACE 34 0.0005
577 QUALITY OF LIFE DECREASED 7 0.0005
578 DECREASED APPETITE 121 0.0005
579 POST PROCEDURAL COMPLICATION 10 0.0005
580 SINUS CONGESTION 7 0.0005
581 HYPERCHOLESTEROLAEMIA 5 0.0005
582 OEDEMA PERIPHERAL 63 0.0005
583 IMPAIRED GASTRIC EMPTYING 7 0.0005
584 THERAPY PARTIAL RESPONDER 8 0.0005
585 SKIN DISORDER 17 0.0005
586 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
587 POLLAKIURIA 21 0.0005
588 SCIATICA 8 0.0005
589 ATRIAL FLUTTER 4 0.0005
590 WOUND 14 0.0005
591 HYPOTONIA 5 0.0005
592 OVARIAN CYST 5 0.0005
593 RESPIRATORY TRACT INFECTION 13 0.0005
594 DYSPNOEA 282 0.0005
595 BLINDNESS UNILATERAL 7 0.0005
596 STEVENS-JOHNSON SYNDROME 11 0.0005
597 ADRENAL INSUFFICIENCY 6 0.0005
598 NOCTURIA 6 0.0005
599 MUSCLE TIGHTNESS 8 0.0005
600 SINUS TACHYCARDIA 7 0.0005
601 BLOOD POTASSIUM INCREASED 8 0.0005
602 ACCIDENTAL OVERDOSE 18 0.0005
603 BLINDNESS 20 0.0005
604 SNEEZING 11 0.0005
605 DISEASE PROGRESSION 58 0.0005
606 CYTOPENIA 6 0.0005
607 ASPHYXIA 4 0.0005
608 SUBDURAL HAEMATOMA 7 0.0005
609 PARALYSIS 7 0.0005
610 HYPOACUSIS 21 0.0005
611 CARDIOMEGALY 6 0.0005
612 PHOTOSENSITIVITY REACTION 8 0.0005
613 CYST 6 0.0005
614 HYPOKINESIA 7 0.0005
615 TOOTH EXTRACTION 6 0.0005
616 EPISTAXIS 36 0.0005
617 FLUID OVERLOAD 7 0.0005
618 LYMPHADENOPATHY 17 0.0005
619 SYNCOPE 48 0.0005
620 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
621 HEPATIC CIRRHOSIS 9 0.0005
622 ACUTE MYOCARDIAL INFARCTION 14 0.0005
623 SCRATCH 5 0.0005
624 HAEMATEMESIS 12 0.0005
625 INCREASED APPETITE 9 0.0005
626 COUGH 132 0.0005
627 CIRCULATORY COLLAPSE 8 0.0005
628 ABDOMINAL DISTENSION 49 0.0005
629 LOWER LIMB FRACTURE 9 0.0005
630 SINUSITIS 48 0.0005
631 RESPIRATORY DISORDER 14 0.0005
632 CONTUSION 45 0.0005
633 FEELING COLD 13 0.0005
634 ASTHENIA 175 0.0005
635 OROPHARYNGEAL PAIN 43 0.0005
636 DECREASED ACTIVITY 5 0.0005
637 DYSPHONIA 27 0.0005
638 OEDEMA 25 0.0005
639 LEUKOPENIA 23 0.0005
640 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
641 EPILEPSY 14 0.0005
642 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
643 WOUND INFECTION 5 0.0005
644 PULMONARY CONGESTION 6 0.0005
645 MELAENA 10 0.0005
646 SARS-COV-2 TEST POSITIVE 6 0.0005
647 MUSCULAR WEAKNESS 51 0.0004
648 GOUT 8 0.0004
649 THROAT IRRITATION 20 0.0004
650 NEPHROPATHY TOXIC 5 0.0004
651 MYELOSUPPRESSION 16 0.0004
652 VERTIGO 27 0.0004
653 ATRIAL FIBRILLATION 43 0.0004
654 IMPAIRED DRIVING ABILITY 5 0.0004
655 ACUTE HEPATIC FAILURE 6 0.0004
656 RIB FRACTURE 9 0.0004
657 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
658 BRAIN NEOPLASM 4 0.0004
659 MUSCLE TWITCHING 10 0.0004
660 HYPOGLYCAEMIA 21 0.0004
661 PERICARDIAL EFFUSION 10 0.0004
662 PRODUCT USE IN UNAPPROVED INDICATION 107 0.0004
663 OVERDOSE 93 0.0004
664 MUSCLE SPASMS 79 0.0004
665 HEPATITIS 11 0.0004
666 RASH MACULAR 15 0.0004
667 APPENDICITIS 4 0.0004
668 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
669 IMPAIRED HEALING 14 0.0004
670 HYPERTENSION 90 0.0004
671 DYSPNOEA EXERTIONAL 16 0.0004
672 HAEMATOMA 11 0.0004
673 BLOOD SODIUM DECREASED 8 0.0004
674 CARDIAC ARREST 35 0.0004
675 EATING DISORDER 9 0.0004
676 ANXIETY 120 0.0004
677 BLOOD IRON DECREASED 5 0.0004
678 ECZEMA 22 0.0004
679 ARTHRITIS 33 0.0004
680 VOMITING 197 0.0004
681 DYSKINESIA 17 0.0004
682 BLOOD PRESSURE FLUCTUATION 10 0.0004
683 DEEP VEIN THROMBOSIS 27 0.0004
684 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
685 LOSS OF CONSCIOUSNESS 53 0.0004
686 BURSITIS 5 0.0004
687 HOT FLUSH 31 0.0004
688 GASTROENTERITIS 6 0.0004
689 CHILLS 48 0.0004
690 DIARRHOEA 264 0.0004
691 RESPIRATORY DEPRESSION 5 0.0004
692 FLATULENCE 23 0.0004
693 URINARY INCONTINENCE 12 0.0004
694 MOVEMENT DISORDER 13 0.0004
695 COLON CANCER 6 0.0004
696 AGEUSIA 10 0.0004
697 CYTOKINE RELEASE SYNDROME 8 0.0004
698 CARDIAC FAILURE CONGESTIVE 32 0.0004
699 GENERAL PHYSICAL HEALTH DETERIORATION 46 0.0004
700 COLD SWEAT 7 0.0004
701 HOSPITALISATION 61 0.0004
702 BACK PAIN 92 0.0004
703 OSTEOPENIA 6 0.0004
704 PRODUCT AVAILABILITY ISSUE 9 0.0004
705 AGITATION 29 0.0004
706 CHRONIC KIDNEY DISEASE 30 0.0004
707 PRODUCT DOSE OMISSION ISSUE 116 0.0004
708 STAPHYLOCOCCAL INFECTION 13 0.0004
709 INTERSTITIAL LUNG DISEASE 19 0.0004
710 INSURANCE ISSUE 6 0.0004
711 HEPATIC CYTOLYSIS 5 0.0004
712 ROTATOR CUFF SYNDROME 5 0.0004
713 ANOREXIA 5 0.0004
714 GASTROENTERITIS VIRAL 7 0.0004
715 TENDONITIS 6 0.0004
716 BLOOD CHOLESTEROL INCREASED 18 0.0004
717 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
718 INJECTION SITE INDURATION 5 0.0004
719 HYPERSOMNIA 11 0.0004
720 BLOOD GLUCOSE INCREASED 72 0.0004
721 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
722 SEIZURE 44 0.0004
723 RENAL IMPAIRMENT 32 0.0004
724 IMMUNE SYSTEM DISORDER 5 0.0004
725 INFLUENZA 42 0.0004
726 METABOLIC ACIDOSIS 12 0.0004
727 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 76 0.0004
728 IRRITABLE BOWEL SYNDROME 8 0.0004
729 RENAL FAILURE 49 0.0004
730 PALLOR 10 0.0004
731 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
732 DIZZINESS 182 0.0004
733 CHOLESTASIS 7 0.0004
734 PERIPHERAL COLDNESS 5 0.0004
735 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
736 NASOPHARYNGITIS 67 0.0004
737 CORONARY ARTERY DISEASE 11 0.0004
738 SPEECH DISORDER 19 0.0004
739 SOMNOLENCE 73 0.0004
740 DRUG LEVEL INCREASED 6 0.0004
741 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
742 MALIGNANT NEOPLASM PROGRESSION 37 0.0004
743 CARDIAC FAILURE 29 0.0004
744 BLOOD PRESSURE DECREASED 24 0.0004
745 FUNGAL INFECTION 12 0.0004
746 TOOTH DISORDER 8 0.0004
747 PLASMA CELL MYELOMA 14 0.0004
748 COORDINATION ABNORMAL 5 0.0004
749 BLISTER 20 0.0004
750 ANGER 12 0.0004
751 WHEEZING 21 0.0004
752 DISORIENTATION 14 0.0004
753 PAIN IN JAW 10 0.0004
754 DIALYSIS 5 0.0004
755 CHEST DISCOMFORT 36 0.0004
756 PERIPHERAL SWELLING 54 0.0004
757 CONFUSIONAL STATE 56 0.0003
758 ANOSMIA 5 0.0003
759 INSOMNIA 92 0.0003
760 FEEDING DISORDER 7 0.0003
761 BODY TEMPERATURE INCREASED 7 0.0003
762 NEUROTOXICITY 6 0.0003
763 HEART RATE DECREASED 12 0.0003
764 ABDOMINAL PAIN UPPER 70 0.0003
765 GAIT DISTURBANCE 65 0.0003
766 DRUG ERUPTION 6 0.0003
767 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
768 THROMBOSIS 27 0.0003
769 ACCIDENT 4 0.0003
770 ABDOMINAL DISCOMFORT 56 0.0003
771 HEART RATE INCREASED 33 0.0003
772 TOOTHACHE 6 0.0003
773 MUSCULOSKELETAL STIFFNESS 29 0.0003
774 HERPES ZOSTER 19 0.0003
775 COVID-19 58 0.0003
776 VIRAL INFECTION 11 0.0003
777 PNEUMONITIS 9 0.0003
778 RESTLESS LEGS SYNDROME 6 0.0003
779 TREATMENT NONCOMPLIANCE 18 0.0003
780 RETCHING 7 0.0003
781 DIABETES MELLITUS 25 0.0003
782 JOINT INJURY 7 0.0003
783 LUNG DISORDER 16 0.0003
784 SKIN DISCOLOURATION 15 0.0003
785 PULMONARY EMBOLISM 31 0.0003
786 LIVER FUNCTION TEST INCREASED 7 0.0003
787 CEREBROVASCULAR ACCIDENT 55 0.0003
788 PRODUCT USE ISSUE 61 0.0003
789 FATIGUE 252 0.0003
790 ANKLE FRACTURE 5 0.0003
791 FEMUR FRACTURE 10 0.0003
792 DRY SKIN 43 0.0003
793 DELUSION 5 0.0003
794 NIGHTMARE 11 0.0003
795 OSTEOPOROSIS 13 0.0003
796 HAEMORRHAGE 33 0.0003
797 MIGRAINE 30 0.0003
798 ANGINA PECTORIS 9 0.0003
799 HYPOAESTHESIA 47 0.0003
800 GLOSSODYNIA 7 0.0003
801 GASTROINTESTINAL DISORDER 28 0.0003
802 THERAPY NON-RESPONDER 14 0.0003
803 INFECTION 45 0.0003
804 EXPOSURE VIA SKIN CONTACT 8 0.0003
805 CHOKING 6 0.0003
806 BLOOD PRESSURE INCREASED 47 0.0003
807 JOINT STIFFNESS 8 0.0003
808 CHOLELITHIASIS 10 0.0003
809 METASTASES TO BONE 5 0.0003
810 BEDRIDDEN 4 0.0003
811 ABNORMAL BEHAVIOUR 12 0.0003
812 NEUTROPENIA 41 0.0003
813 RENAL DISORDER 14 0.0003
814 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 54 0.0003
815 MENTAL DISORDER 13 0.0003
816 HEPATIC FAILURE 9 0.0003
817 FULL BLOOD COUNT DECREASED 6 0.0003
818 PERICARDITIS 5 0.0003
819 FEAR 8 0.0003
820 DYSGEUSIA 22 0.0003
821 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
822 TREMOR 49 0.0003
823 DRUG TOXICITY 4 0.0003
824 MUSCULOSKELETAL DISCOMFORT 5 0.0003
825 PARANOIA 5 0.0003
826 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
827 FIBROMYALGIA 7 0.0003
828 NERVOUSNESS 15 0.0003
829 ROAD TRAFFIC ACCIDENT 12 0.0003
830 PRURITUS 110 0.0003
831 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
832 MYALGIA 48 0.0003
833 PAIN IN EXTREMITY 83 0.0003
834 IMPAIRED WORK ABILITY 6 0.0003
835 BRONCHOSPASM 4 0.0003
836 POOR QUALITY SLEEP 6 0.0003
837 UNEVALUABLE EVENT 21 0.0003
838 PANCREATIC CARCINOMA 8 0.0003
839 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
840 RASH 120 0.0003
841 PELVIC PAIN 5 0.0003
842 ARRHYTHMIA 13 0.0003
843 END STAGE RENAL DISEASE 5 0.0003
844 INTENTIONAL PRODUCT MISUSE 24 0.0003
845 DYSSTASIA 8 0.0003
846 THERAPY CESSATION 14 0.0003
847 RASH ERYTHEMATOUS 13 0.0003
848 HYPERHIDROSIS 35 0.0003
849 UNRESPONSIVE TO STIMULI 7 0.0003
850 BURNING SENSATION 19 0.0003
851 RASH GENERALISED 7 0.0003
852 INJURY 19 0.0003
853 CONDITION AGGRAVATED 82 0.0003
854 ARTHRALGIA 112 0.0003
855 RASH PAPULAR 6 0.0003
856 PARAESTHESIA 42 0.0003
857 PANCREATITIS ACUTE 6 0.0003
858 FOOT FRACTURE 5 0.0003
859 URTICARIA 44 0.0003
860 SKIN EXFOLIATION 22 0.0003
861 HYPERSENSITIVITY 48 0.0003
862 JOINT SWELLING 31 0.0003
863 SURGERY 15 0.0003
864 BRAIN FOG 4 0.0003
865 KIDNEY INFECTION 5 0.0003
866 RESPIRATORY ARREST 7 0.0003
867 ANAPHYLACTIC REACTION 14 0.0003
868 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
869 DISEASE RECURRENCE 12 0.0003
870 ARTHROPATHY 14 0.0003
871 UPPER LIMB FRACTURE 5 0.0003
872 BLOOD GLUCOSE DECREASED 12 0.0002
873 ANGIOEDEMA 11 0.0002
874 MUSCULOSKELETAL PAIN 13 0.0002
875 LIVER DISORDER 11 0.0002
876 ASTHMA 28 0.0002
877 MEMORY IMPAIRMENT 34 0.0002
878 UNDERDOSE 18 0.0002
879 DEPRESSED MOOD 13 0.0002
880 PULMONARY OEDEMA 11 0.0002
881 ADVERSE DRUG REACTION 22 0.0002
882 LIVER INJURY 6 0.0002
883 ENCEPHALOPATHY 6 0.0002
884 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
885 EXTRAPYRAMIDAL DISORDER 6 0.0002
886 WEIGHT INCREASED 54 0.0002
887 DISTURBANCE IN ATTENTION 13 0.0002
888 SLEEP DISORDER 17 0.0002
889 EXPIRED PRODUCT ADMINISTERED 8 0.0002
890 NEEDLE ISSUE 7 0.0002
891 LIP SWELLING 8 0.0002
892 PALPITATIONS 28 0.0002
893 BONE PAIN 14 0.0002
894 HALLUCINATION 18 0.0002
895 LABORATORY TEST ABNORMAL 7 0.0002
896 FACE OEDEMA 4 0.0002
897 ERECTILE DYSFUNCTION 6 0.0002
898 IRRITABILITY 14 0.0002
899 SKIN CANCER 5 0.0002
900 APHASIA 7 0.0002
901 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
902 MULTIPLE SCLEROSIS 11 0.0002
903 PRODUCT DOSE OMISSION 15 0.0002
904 PRODUCT PRESCRIBING ISSUE 5 0.0002
905 DEAFNESS 6 0.0002
906 FEELING HOT 14 0.0002
907 EOSINOPHILIA 4 0.0002
908 EAR INFECTION 6 0.0002
909 SWOLLEN TONGUE 7 0.0002
910 ORAL PAIN 5 0.0002
911 BONE DISORDER 4 0.0002
912 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
913 RESTLESSNESS 8 0.0002
914 PRODUCT STORAGE ERROR 19 0.0002
915 INJECTION SITE MASS 8 0.0002
916 FLUID RETENTION 11 0.0002
917 RHABDOMYOLYSIS 9 0.0002
918 DEPRESSION 49 0.0002
919 CARDIO-RESPIRATORY ARREST 9 0.0002
920 BACTERIAL INFECTION 4 0.0002
921 ALOPECIA 42 0.0002
922 INFLAMMATION 11 0.0002
923 DYSARTHRIA 8 0.0002
924 FRACTURE 4 0.0002
925 SUICIDAL IDEATION 19 0.0002
926 INFLUENZA LIKE ILLNESS 17 0.0002
927 PRODUCT QUALITY ISSUE 28 0.0002
928 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
929 TREATMENT FAILURE 17 0.0002
930 ILLNESS 21 0.0002
931 RENAL INJURY 6 0.0002
932 NEOPLASM PROGRESSION 7 0.0002
933 PRODUCT COMPLAINT 5 0.0002
934 BONE MARROW FAILURE 4 0.0002
935 NEOPLASM MALIGNANT 13 0.0002
936 LIMB DISCOMFORT 6 0.0002
937 RHEUMATOID ARTHRITIS 22 0.0002
938 NERVOUS SYSTEM DISORDER 6 0.0002
939 FEELING ABNORMAL 46 0.0002
940 HEPATIC ENZYME INCREASED 13 0.0002
941 PANCREATITIS 10 0.0002
942 THROAT TIGHTNESS 5 0.0002
943 DEATH 159 0.0002
944 AMNESIA 12 0.0002
945 CARDIAC DISORDER 17 0.0002
946 DRUG DOSE OMISSION 30 0.0002
947 THERAPEUTIC RESPONSE DECREASED 11 0.0002
948 GAIT INABILITY 6 0.0002
949 CHROMATURIA 4 0.0002
950 PSORIATIC ARTHROPATHY 7 0.0002
951 SWELLING 16 0.0002
952 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
953 RASH PRURITIC 9 0.0002
954 SUICIDE ATTEMPT 10 0.0002
955 ADVERSE EVENT 15 0.0002
956 ABASIA 4 0.0002
957 DEVICE DISLOCATION 7 0.0002
958 AGGRESSION 8 0.0002
959 FLUSHING 16 0.0002
960 CONVULSION 9 0.0002
961 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
962 SKIN IRRITATION 7 0.0002
963 ANHEDONIA 4 0.0002
964 GASTRIC DISORDER 5 0.0001
965 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
966 CRYING 5 0.0001
967 MYOCARDIAL INFARCTION 24 0.0001
968 DEVICE ISSUE 12 0.0001
969 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
970 INCORRECT DOSE ADMINISTERED 29 0.0001
971 INJECTION SITE PAIN 36 0.0001
972 DRUG EFFECT INCOMPLETE 4 0.0001
973 MEDICATION ERROR 6 0.0001
974 ACNE 8 0.0001
975 DRUG INTOLERANCE 10 0.0001
976 PSORIASIS 13 0.0001
977 DEVICE DIFFICULT TO USE 6 0.0001
978 INJECTION SITE BRUISING 7 0.0001
979 BREAST CANCER 8 0.0001
980 COMA 4 0.0001
981 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
982 DERMATITIS ATOPIC 4 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
984 DEVICE MALFUNCTION 5 0.0001
985 INJECTION SITE ERYTHEMA 8 0.0001
986 EXPOSURE DURING PREGNANCY 4 0.0001
987 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
988 NO ADVERSE EVENT 11 0.0001
989 DRUG WITHDRAWAL SYNDROME 4 0.0000
990 DRUG DEPENDENCE 7 0.0000